Physician profile
Xin Yang
NPI 1851896708
$804.79
in general payments reported to CMS, 2019-2025
6 companies · $789 in 2025
The $789 reported for 2025 was more than what 88% of Neurocritical Care providers received nationally (typical 2025 total: $95.82).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.25 · 2025: $789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $399 · Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $398.85 |
| Food and Beverage | $389.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $398.85 | 2025 | Trufill |
| Penumbra, INC. | $167.48 | 2025 | Red 72 |
| Depuy Synthes Sales INC. | $138.75 | 2025 | Trufill, Emboguard, Cerepak Uniform |
| Asahi Intecc USA, INC. | $60.30 | 2025 | Asahi Neurology Wires |
| Cardiva Medical, INC. | $23.16 | 2025 | Cardiva Vascade 6/7f Vcs |
| Upsher-Smith Laboratories LLC | $16.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xin Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.